Tuesday, November 28, 2006 8:00:00 AM PDT | VentureDeal Staff
TUCSON, AZ -- AmpliMed Corporation announced the second closing of its Series B financing round with an additional $8.5 million in new investment.The Series B round was led by Biotech Insight Ventures and included InvestBio Ventures, Valley Ventures and Solstice Capital.The company, which is in clinical trials for drug treatments of skin and pancreatic cancer, will use the funds to complete current trials and launch into the next phase of its clinical development program.
Email Page | Print Page
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
